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Abstract 
Spherical unimolecular amphiphilic branched A-B block copolymer 
nanoparticles in methanol are fabricated via thermal annealing 
using the methanolic upper critical solution temperature (UCST) of 
the hydrophobic block segment. This finding is then used to 
produce aqueous poorly water-soluble drug nanoparticle 
suspension with a mass:drug ratio of 1:1 and 100% nanoparticle 
yield. The drug nanoparticles in the suspension are stabilized by 
multiple polymer nanoparticles. 
The synthesis of polymer nanoparticles has attracted 
significant attention due to potential applications from 
drug/nucleic acid delivery systems 1,2 to templating agents for 
nanoporous microelectronic materials.3 A multitude of 
approaches have been reported to generate polymer 
nanoparticles with controlled size, shape and chemical 
functionality including dendrimer synthesis (size ranging from  1 
to 10 nm),  microemulsion polymerization techniques (particles 
from 20 to 50 nm)  and emulsion/evaporation techniques.4-6 
Indirect formation of nanostructures by cooperative self-
assembly of pre-synthesized macromolecular building blocks 
has also been reported, with cross-linking of self-assembled 
structures utilized to generate persistent particles.7-9 In general, 
self-assembly and subsequent crosslinking is relatively time-
consuming, requires careful control of concentrations during 
the reactions and presents difficulties for scale-up.  We have 
reported a direct monomer-to-particle synthetic strategy based 
on branched amphiphilic A-B block copolymers. 10, 11 Using the 
atom transfer radical polymerization (ATRP) technique to form 
soluble high molecular weight species, well-defined spherical 
polymer nanoparticles could be obtained after a dialysis process 
of the polymer solution in tetrahydrofuran (THF) against water. 
This synthetic approach differs significantly from the reported 
arm-first or core-first core-crosslinked star-polymer synthesis 
where the core is effectively a highly cross-linked microgel 
formed by the addition of a large volume of a cross-linker such 
as divinylbenzene at the end of the polymerisation. 12,13 It was 
possible to further prepare amphiphilic materials with defined 
nanoparticle shape in a one-pot, concerted growth process 
rather than joining of pre-formed spheres.10,11 Apart from the 
direct synthetic method, the branched polymer nanoparticles 
have several additional advantages over conventional micelles 
and dendrimers; the high stability which means that they would 
retain their sizes and spherical shapes when applied in vivo, and 
would not disassemble when environmental conditions changes 
(compared to conventional micelles), would also allow larger 
loading capacity of guest compounds (compared to highly-
crosslinked nano/micro gels) due to light crosslinking, and the 
high potential to be scaled-up. 
For biomedical or environmental applications, aqueous 
formulations are often required for hydrophobic organic 
compounds. Particularly for poorly water-soluble drugs, where 
a high percentage of developed drug compounds are poorly 
water-soluble, the low water solubility can lead to low 
therapeutic efficacy and sometimes the drug candidate 
compounds would have to be abandoned.14 One promising way 
to address this issue is the preparation of aqueous drug 
nanoparticle dispersions. The nanoformulations can enhance 
the dissolution rate or can be used directly as evidenced by the 
nanodrugs on the market.14 Both top-down (milling, 
homogenization) and bottom-up methods (e.g., micelles, 
dendrimers, emulsion evaporation) have been widely 
reported.14, 15 An excellent formulation method should have the 
characteristics of mild processing conditions, use of intoxic 
solvent, small nanoparticles, high loading of active drugs, etc. 
Very recently, we have reported the use of branched 
copolymer nanoparticles poly(N-isopropyl acrylamide)-b-poly 
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(ethylene glycol) (PNIPAM-PEG)  for preparation of aqueous 
drug nanoparticle dispersions via an emulsion freeze-drying 
approach.16 The hydrophobic drugs were dissolved in water-
immiscible organic solvent which was then formulated to form 
oil-in-water emulsions before applying the emulsion freeze-
drying procedure. There are a few issues unfavoured in that 
technique: (i) the volatile organic solvent may be toxic; (ii) many 
drugs are only soluble in polar organic solvent (e.g., alcoholic 
solvent, acetone) and cannot be further processed to form 
emulsions; (iii) use of energy-intensive freeze-drying technique. 
Herein, we describe the synthesis of branched copolymer of 
POEGMA-PnBMA (a more hydrophobic core) from 
oligo(ethylene glycol mono-methyl ether) methacrylate 
(OEGMA) and n-butyl methacrylate (n-BMA). Importantly, we 
report for the first time the formation of such polymer 
nanoparticles by thermal annealing of its methanolic solution. 
Instead of a two-step procedure (preparation of THF solution 
followed by the time-consuming dialysis process in water) 
reported previously,10,11 the simple thermal annealing method 
allows the quick formation of polymer nanoparticles in water 
(usually within one hour). The finding is then employed for the 
preparation of drug nanoparticle suspensions by a simple 
solvent evaporation approach.  
Scheme 1. Schematic synthesis of p(OEGMA-b-(nBMA-co-
EGDMA)) amphiphilic branched A-B block copolymers. A) ATRP 
sequential polymerization of OEGMA and a mixed monomer 
nBMA/EGDMA feedstock; B) Branched A-B block copolymers 
precipitate in methanol and subsequently dissolve on heating 
through the UCST.  
 
The synthesis of the amphiphilic A-B branched block 
copolymers (and their linear analogues) consisted of a one-pot, 
Cu(I)Br/2,2-bypridine catalysed, ATRP polymerisation in 
isopropanol (IPA), using an  ethyl α-bromoisobutyrate (EBriB) 
initiator to polymerise OEGMA (Mn = 300 g/mol) to a relatively 
low degree of polymerization (DP). Addition of a mixture of n-
butyl methacrylate (nBMA) and ethylene glycol dimethacrylate 
(EGDMA) to the growing p(OEGMA) chain allowed propagation 
of hydrophobic p(nBMA) with simultaneous branching to other 
propagating chains (Scheme 1A). Careful manipulation of the 
EGDMA/EBriB ratio and monomer concentrations prevents 
gelation and ensures, on average, less than one branching 
EGDMA per primary polymer chain.17 The synthesized branched 
polymers were characterized by 1H NMR and gel permeation 
chromatography (GPC), as shown in Figure S1 and S2 for 
p(OEGMA36-b-(nBMA60-co-EGDMA0.9)). The original feeding 
ratio of OEGMA:nBMA was 40:60. The component ratio in the 
polymer was calculated from the 1H NMR spectrum (Figure S1). 
Due to the high molecular weights of each block copolymer 
linear chain (e.g., around 18000 gmol-1), it was difficult to find 
the remaining initiator peaks and obtain the accurate integral 
value to calculate the 1H NMR Mw. But the integral values of 
methylene groups from PnBMA and methyl groups form 
POEGMA could be used to calculate the ratio of each blocks, 
which gave a ratio of OEGMA:nBMA = 36:57. This is consistent 
with the conversions of 90 % and 98% for OEGMA and nBMA 
after polymerisation, respectively. During the GPC analysis, very 
high operation pressure was noticed and it was likely that most 
of the branched polymer could ‘stick’ to the stationary phase 
and be trapped in the GPC column.10 Although larger molecules 
are usually easily eluted out in the GPC analysis, the high 
molecular weight and larger size of the branched copolymer 
may interact strongly with the stationary phase, accumulate, 
and partially block the pores in the column, as evidenced by the 
high back pressure. This resulted in the elution of small amount 
of poorly-branched copolymers, which could be detected by the 
GPC (Figure S2). This data may be not accurate, but it still 
indicates the formation of branched structures (relatively big 
polydispersity and Mw). 
 
 
Figure 1. P(nBMA) at diﬀerent temperatures in MeOH – (i) at 
25oC prior to heating(precipitate at bottom) (ii) 55-60oC, and (iii) 
after cooling to 25oC. 
 
Although p(nBMA) is considered to be hydrophobic, the 
polar solvent IPA is the theta solvent for the polymer,18 allowing 
successful ATRP of nBMA in IPA and H2O/IPA mixtures.19 
Methanol is normally a poor solvent for p(nBMA) and often 
used during workup at ambient or chilled temperature to 
precipitate p(nBMA) after synthesis. However, during a study of 
p(nBMA) (Mn= 13570 g mol-1), the precipitated polymer in 
methanol was heated to temperatures approaching the boiling 
point of MeOH. Surprisingly, it was noticed that the polymer 
dissolved fully to produce a clear solution which precipitated 
again when the solution returned to ambient temperature 
(Figure 1). This behaviour could be utilized to conduct Cu-
catalyzed ATRP of nBMA within methanol under different 
temperatures to generate linear homopolymers with a wide 
range of molecular weights whilst maintaining very low 
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dispersities and avoiding termination reactions that would lead 
to increasing molecular weight at high monomer conversions.20 
It should be pointed out that only linear polymers were 
produced and no nanoparticle study was carried out in the 
previous study.20 Thus, the novelty of this study in preparing the 
branched block copolymer and utilizing it to form polymer 
nanoparticles is still high. 
The upper critical solution temperature (UCST) behaviour of 
p(OEGMA) in octan-1-ol was used to create micelles, prior to 
crosslinking of linear di-block copolymers containing OEGMA, 
N-isopropyl acrylamide, pentafluorophenyl acrylate and N,N-
diethylacrylamide.21,22 Similarly, statistical copolymers of N-
phenyl maleimide and n-octadecyl vinyl ether were shown to 
exhibit UCST behaviour in N,N-dimethylformamide and a range 
of alcohols such as 1-butanol and 1-hexanol23 whilst p(BMA) 
and p(BMA) A-B block copolymers with PEG were reported to 
exhibit lower critical solution temperature (LCST) behaviour in 
ionic liquids.24  
 
Figure 2. Characterisation of p(OEGMA36-b-(nBMA-co-
EGDMA0.9)) branched A-B block copolymer nanoparticles and 
corresponding linear analogue after annealing the solutions 
through the methanolic UCST. A) Dynamic light scattering of 
branched copolymer nanoparticles: blue large dashed line, 
p(BMA) block DP = 60; black short dashed line, p(BMA) block DP 
= 40; green triple dashed line, p(BMA) block DP=20; red solid 
line, linear p(OEGMA36-b-nBMA54) control. TEM images of B) 
linear p(OEGMA36-b-nBMA54), and branched copolymers where 
C) p(BMA) block DP = 60; D) p(BMA) block DP = 40; E) p(BMA) 
block DP = 20 and F) branched copolymer nanoparticles of 
p(OEGMA36-b-(nBMA60-co-EGDMA0.9)) after annealing in 
methanol and dialysis into water. 
 
The dissolution of p(nBMA) in warm methanol offers an 
alternative route to nanoparticle formation after synthesis of 
the branched A-B block copolymers. The synthesized branched 
block POEGMA-PnBMA was added to methanol at ambient 
temperature (10mg/10ml, polymer/methanol) and heated with 
stirring to 55-60°C for 10 minutes and subsequently allowed to 
cool (Scheme 1B). At ambient temperature a clear solution was 
seen with no obvious precipitate. Methanol is a good solvent for 
the p(OEGMA) block and dissolves the branched p(BMA-
EGDMA) core block at elevated temperature. Therefore, we 
postulated the formation of discreet, unimolecular 
nanoparticles during cooling of the dilute MeOH solution and 
collapse of the insoluble branched block segments (Scheme 1B). 
 In this work, a range of polymers were synthesized with the 
same degree of polymerization (DP) of p(OEGMA) and 
decreasing block length of the branched p(nBMA), i.e., 
p(OEGMA36-b-(nBMA60-co-EGDMA0.9)), p(OEGMA36-b-(nBMA40-
co-EGDMA0.9)), p(OEGMA36-b-(nBMA20-co-EGDMA0.9)). A linear 
A-B block copolymer analogue, p(OEGMA36-b-nBMA54), was 
also synthesized and processed in the same manner. After the 
thermal annealing procedure, transmission electron 
microscopy (TEM) and dynamic laser scattering (DLS) analysis of 
the polymer solutions in methanol was conducted. The 
presence of nanoparticles is clearly demonstrated in Figure 2. In 
methanol, the Z-average nanoparticle diameters varied from 37 
nm to 33 nm to 25 nm in relation to the decreasing p(nBMA) 
chain length (DP= 60, 40 and 20 monomer units respectively) 
for the branched copolymers. However, for the linear block 
copolymer, there were no particles larger than 10 nm, assumed 
to be the single linear block copolymers with solvated 
p(OEGMA) segments. Accordingly, by TEM, irregular films were 
generated by the annealed and dried MeOH solutions of linear 
p(OEGMA36-b-nBMA54) (Figure 2B) whilst spherical 
nanoparticles were observed for three branched block 
copolymers with different chain lengths of p(nBMA), showing 
slightly larger sizes 48nm, 40nm and 28nm, respectively (Figure 
2C-E). This is likely due to spreading of the low Tg p(OEGMA 
corona and p(nBMA) cores. The MeOH suspension of 
p(OEGMA36-b-(nBMA60-co-EGDMA0.9)) nanoparticles was 
dialysed to transfer the nanoparticles from MeOH to H2O. After 
dialysis for 1 day, aqueous nanodispersion was obtained and 
analyzed by DLS and TEM with almost identical sizes seen in 
water: TEM diameter = 45 nm and DLS Z-average = 32 nm 
(Figure 2F). This indicates that, as an alternative way to prepare 
polymer nanoparticles, the thermal annealing method can 
produce polymer nanoparticles of similar sizes, but more 
efficient as it takes much less preparation time. 
 Figure 3. DLS profiles of ketoprofen nanoparticles formed by 
direct solvent evaporation of p(OEGMA-b-nBMA) (DPs of 36/40 
and 36/60) and ketoprofen (mass ratio 1:1) in MeOH/H2O (1:1 
v/v).  
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Linear and block copolymers have been used to produce 
hydrophobic drug nanoparticles, usually be solvent 
displacement or nanoprecipitation.14 Commonly, the polymers 
would be dissolved in a water-miscible solvent (e.g., acetone, 
THF) and the resulting solution is added dropwise into water. 
After evaporation of the volatile organic solvent, drug-
encapsulated polymer nanoparticles can be obtained. Whether 
drug nanoparticles in water can be formed may depend on the 
type of polymer, hydrophobic drug/compound, type of solvent, 
concentration of solutions. The preparation conditions need to 
be optimized to form nanoparticles with desirable sizes (e.g., < 
200 nm) and high yield. Here, we demonstrate how the 
P(OEGMA)-P(nBMA) nanoparticles can be used to facilitate the 
formation of poorly water-soluble drug nanoparticles, using 
ketoprofen as the model drug. P(OEGMA)-P(nBMA) (the as-
synthesized polymer, not the nanoparticles after dialysis against 
water) and ketoprofen were dissolved in warm methanol at 
55oC, cooled down to room temperature. At this stage, 
ketoprofen was still dissolved but with polymer nanoparticles 
(induced by thermal annealing) in methanol, whilst both the 
drug and polymer would be molecularly dissolved in the 
previous nanoprecipitation or solvent evaporation approach. 
After adding equal volume of water to the methanol 
suspension, methanol was allowed to evaporate at room 
temperature in a fume cupboard to produce aqueous 
ketoprofen nanoparticle suspension directly.  
At a ketoprofen:POEGMA-PnBMA ratio of 1:1, a 
nanoparticle yield of 100% was achieved. As measured by DLS, 
the Z-average nanoparticle sizes by intensity were 198 nm and 
214 nm for p(OEGMA36-b-(nBMA60-co-EGDMA0.9) and 
p(OEGMA36-b-(nBMA40-co-EGDMA0.9), respectively. The DLS 
profiles showed quite narrow particle size distributions for both 
aqueous ketoprofen nanoparticle suspensions (Figure 3). It was 
also found that when the polymer ratio was higher, e.g., 
polymer:drug = 3:1, the nanoparticle yields of 100% were also 
achieved. This is understandable because more polymer can 
better stabilize the hydrophobic drug nanoparticles. We also 
tried the ratio of polymer:drug = 1:3. The nanoparticle yields of 
81% and 85% for ketoprofen were obtained for p(OEGMA36-b-
(nBMA40-co-EGDMA0.9) and p(OEGMA36-b-(nBMA60-co-
EGDMA0.9), respectively. The nanoparticle yield was calculated 
as the percentage of ketoprofen nanoparticles in the 
suspension after centrifugation (see the Experimental in the 
Supporting Information), stabilized by the branched copolymer 
nanoparticles, based on the amount of ketoprofen used in the 
preparation. It should be noted that at the centrifugation speed 
of 3000 rpm, all the polymer nanoparticles still remained in the 
suspension and provided stabilization for the ketoprofen 
nanoparticles. Based on the amount of ketoprofen used, 
ketoprofen loading efficiency should be the same as the 
ketoprofen nanoparticle yields. However, the loading 
percentages of drug nanoparticle in the formulation (i.e., taking 
both drug and polymer nanoparticles into account) should be 
50 % for drug:polymer = 1:1 at 100 % nanoparticle yield, 63.75 
% for 85 % nanoparticle yield  and 60.75 % for 81% nanoparticle 
yield both at drug:polymer =3:1. 
The branched block copolymers form unimolecular 
nanoparticles in methanol and water, as discussed and 
demonstrated in Figure 2. However, the polymer-stablized 
ketoprofen nanoparticles are multimolecular. This may be 
explained by Scheme 2.  
 
Scheme 2. Formation of ketoprofen nanoparticles assisted by 
branched block copolymers via solvent evaporation 
 
The block copolymer POEGMA-PnBMA forms clear solution 
as swollen nanoparticles in methanol at 55 oC and nanoparticle 
suspension with dense hydrophobic core at room temperature. 
During the preparation, POEGMA-PnBMA and the drug 
compound are dissolved in methanol to form clear solution at 
55oC. When cooling to room temperature, the polymer 
nanoparticles with dense PnBMA core with some ketoprofen 
molecules are formed while the rest of ketoprofen is still soluble 
in methanol. When adding water to the methanol solution, with 
the evaporation of methanol, the increasing hydrophilic 
environment drives the hydrophobic drug molecules moving 
towards the hydrophobic core (which may be just on or close to 
the core due to the dense nature in methanol at room 
temperature), with the whole structure stabilized by the outer 
hydrophilic PEG chains. With further evaporation, more drug 
can be loaded into the polymer nanoparticles core, and the 
nanoparticles core becomes more hydrophobic and solid. This 
makes the outer PEG chains difficult to stabilize each 
nanoparticles, which resulted in the aggregation of several 
nanoparticles and resulted in bigger nanoparticles (Scheme 2). 
It is clear that although the block copolymer nanoparticles are 
unimolecular, the drug-polymer nanoparticles are 
multimolecular. To be more precise, the hydrophobic drug 
nanoparticles are stabilized by multiple polymer nanoparticles. 
This explanation was supported by the control experiment of 
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evaporating methanol from the methanol solution (without 
adding water) directly. Low nanoparticle yields were recorded 
(Table S1), which could be the result of low capacity and drive 
for the drug molecules to move into the dense PnBMA core. The 
drug molecules could just form large particles outside the 
POEGMA-PnBMA nanoparticles.  
In summary, a branched A-B block copolymer comprising 
p(OEGMA) and branched p(BMA) block segments has been 
synthesized and employed to form nanoparticles in methanol 
via a thermal annealing process using the methanolic UCST of 
the hydrophobic block p(BMA). The z-average diameter of the 
particles (25-37nm) is controlled by the number average degree 
of polymerisation of the hydrophobic block p(BMA). These 
polymer nanoparticles are utilized to produce aqueous drug 
nanoparticle dispersion by a simple solvent evaporation 
approach. By design and careful selection of block monomers 
and block chain length, one may be able to synthesize and 
optimize the block copolymer structure for a target organic 
compound. The combination of solvent evaporation and 
branched block polymer can be a very effective method in 
organic nanoparticles and nanomedicine research. 
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Experimental Details  
 
Chemicals and reagents  
Deionized water was prepared using an AquaMAX-Basic 321 DI water purification system. Ketoprofen ≥ 98% (TLC), 
copper (I) bromide (CuBr, 98%), copper (I) chloride (CuCl, 99+%), 2,2-dipyridyl (bpy, 99+%),  ethyl 2-
bromoisobutyrate (EBriB, 98%), Azobis-(isobutyronitrile) (AIBN),  and 1-dodecanethiol (DDT)were purchased from 
Sigma-Aldrich and used as received. Olig(ethylene glycol) methyl ether methacrylate (OEGMA, Mn = 300 g/mol), 
ethylene glycol dimethacrylate (EGDMA, 98%) were obtained from Sigma-Aldrich, and passed through an 
aluminium oxide (Al2O3) column to remove the inhibitor before use. Tetrahydrofuran (THF) from Aldrich was 
purified by refluxing with sodium overnight under nitrogen to remove water, then distilled prior to use. All other 
solvents were purchased from Sigma-Aldrich and used as received.  
 
Synthesis of branched diblock copolymer P(OEGMA)-P(nBMA) by ATRP using EBriB (ethyl 2-bromoisobutyrate) as 
the initiator. 
Typically, synthesis of P(OEGMA)36-P(nBMA)40 could be described as follows: into a Schlenk flask (50 ml) was added 
OEGMA (2.04 g, 6.8 mmol), CuBr (24.5 mg, 0.17 mmol), bipyridine (bpy) (53.1 mg, 0.34 mmol) and solvent 
(isopropanol/water (92.5/7.5 v/v; 4.2 ml) and anisole (0.3 ml; internal standard for 1H NMR). The reaction mixture 
was bubbled with nitrogen for 40 minutes to completely remove the oxygen. A small sample was taken for 1H NMR 
analysis, followed by the addition of EBriB (25.0 μL, 33.2 mg, 0.17 mmol) using a microsyringe. The polymerization 
was carried out at ambient temperature (~20 oC) under N2. Samples were taken periodically from the reaction 
mixture during polymerization for 1H NMR analysis to measure the monomer conversion. In a second 50 ml Schlenk 
flask, CuCl (16.9 mg, 0.17 mmol), 2,2-bypridine  (53.1 mg, 0.34 mmol), n-butyl methacrylate (n-BMA) (0.965 g, 6.8 
mmol), EGDMA (29.2mg, 0.15 mmol) and 5.8 ml of the water-alcohol solvent mixture were added, and this mixture 
was bubbled with N2 for 1 h.  After the conversion of OEGMA reached around 90%, the mixture from the second 
flask was added into the first flask rapidly using a syringe and taking care not to admit any air into the vessel. A 
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sample was taken immediately after the addition of the n-BMA monomer solution for 1H NMR analysis. The block 
copolymerization reaction was carried at ambient temperature and samples were taken periodically from the 
reaction mixture for 1H NMR analysis. After the monomer conversion reached above 95%, the polymerization was 
stopped by adding THF into the reaction mixture and exposing the sample. The mixture was passed through an 
Al2O3 column to remove the copper species and the branched copolymer was obtained after reprecipitation in cold 
hexane three times and drying in a vacuum oven overnight.  
 
Nanoparticle formulation by solvent evaporation  
40 mg of POEGMA-b-nBMA (DP 36/60 and 36/40) and 40 mg drug (ketoprofen, anthracene and OR) were stirred in 
5 ml methanol for 20 min at room temperature (20 °C). The samples were then heated to 56  ̊C and stirred at 5000 
rpm for further 20 min. After cooling to room temperature, 5 ml deionized water was added. It was noticed that 
the solution with POEGMA-b-nBMA (DP 36/40) turned opaque while the solution with POEGMA-b-nBMA (DP 36/60) 
was still clear. Another procedure was to directly process the methanol solution at room temperature. Methanol 
was evaporated off at room temperature in the fume cupboard.  After evaporation of methanol, the samples with 
added water produced aqueous suspensions, which were analysed directly. The dry samples formed from methanol 
solution after evaporation were dissolved in 5 ml water to form suspensions for measurement.  
 
Characterisation 
The 1H NMR spectra were recorded using an Agilent VNMRS600 instrument at 600 MHz. Samples were 
analyzed at room temperature and CDCl3 was used as the solvent for all the samples. Gel Permeation 
Chromatograph (GPC) results were obtained using a Viscotek system employing OmniSEC 4.2 software, 
TDA Model 302 (right-angle & low-angled light scattering, refractive index, ultra-violet and viscometer 
detectors all in a temperature controlled oven (set at 35 °C)) coupled to a gpcMAX integrated solvent and 
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sample delivery module (degasser, pump and autosampler).  The system was fitted with a ViscoGEL HHR-
H guard column and two ViscoGEL GMHHR-M columns (also stored in the detector oven at 35 °C), at a 
flow rate of 1 ml/min, using tetrahydrofuran (THF), (GPR, stabilized with BHT (VWR, UK)) as the eluent and 
with an injection volume of 100 μl. 
 
Particle sizes and Zeta-potentials were measured by dynamic laser scattering (DLS) analysis on a Malvern Zetasizer 
Nanoseries at 25 °C from Malvern Instruments. The measurements were performed on aqueous nanoparticles 
suspensions with a concentration of ~ 0.2 mg/ml. Microparticles or aggregates were removed by centrifugation 
with an Eppendorf Centrifuge 5415 D at 3000 rpm for 3 minutes and one minute at 3600 rpm to ensure that larger 
particles precipitate. 
 
The branched copolymer nanoparticles were analyzed using a Tecnai Spirit transmission electron microscope (TEM) 
(Tecnai G2 12) with an accelerating voltage of 100 KV. Sample solutions were dropped onto 400 mesh copper TEM 
grids, and dried overnight at room temperature.  Imaging at multiple spots was undertaken over several areas of 
the TEM grid to ensure that the analysis was representative of the sample. 
 
Determination of Nanoparticle yield 
Evaporated samples were dispersed into DI water. Microparticles and aggregates were precipitated by 
centrifugation for 3 minute at 3000 rpm and a further minute at 3600 rpm on an Eppendorf Centrifuge 5415 D. 
After the processing, the hydrophobic drug compound is transferred into drug nanoparticles (in the suspension 
after centrifugation) and large microparticles/aggregates (precipitated after centrifugation). The nanoparticles yield 
is the percentage of the drug compound transformed into nanoparticles, based on the total amount of the 
hydrophobic drug used. The nanoparticle yield can be calculated as below: 
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𝑌𝑖𝑒𝑙𝑑 =
𝑚𝑁𝑃
𝑚𝑇
×  100 =
𝑚𝑆
𝑚𝑆 + 𝑚𝑃
× 100 
𝑚𝑇 = 𝑚𝑆 + 𝑚𝑃 
Where mNP is the mass of nanoparticles, mT the total mass of added drug compound, mS the mass of particles in the 
suspension after centrifuging, and mP the mass of precipitated particles after centrifuging. 
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Figure S1. The 1HNMR spectrum for the sample p(OEGMA36-b-(nBMA60-co-EGDMA0.9))  
COMMUNICATION Journal Name 
12  |  J. Name. , 2012, 00,  1-3  This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
 
 
 
 
Figure S2. The GPC chromatogram for the sample p(OEGMA36-b-(nBMA60-co-EGDMA0.9)), column set HHR-H 
and 2xGMHHR-M, eluent 1 ml/min THF, 100 μl injection (RI (red), DP (blue), RALS (green), LALS (black)). Mw: 
286,030, Mn: 94,598, PDI: 3.10.  
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Table S1. DLS data of the nanosuspensions formed by evaporating methanol solution at room temperature and re-
dispersion in water 
 
  
Sample name 
DP  
OEGMA/nBMA 
Drug 
Drug:Polymer 
Ratio 
Z-Average 
[nm] 
Number % 
[nm] 
PDI 
Yield 
[%] 
1* 36/60 Ketoprofen 1:1 - - - - 
2 36/40 Ketoprofen 1:1 80 ± 2 
34 ± 5 0.38  
 
* no measurement possible due to sample agglomerating. 
 
 
